Trauma-induced coagulopathy-A review of the systematic reviews: Is there sufficient evidence to guide clinical transfusion practice?

Transfusion Medicine Reviews

Volumn 25, Issue 3, 2011, Pages

  Curry, Nicola ^a,b,c,d,e   Stanworth, Simon ^a,b,c,d,e   Hopewell, Sally ^a,b,c,d,e   Dorée, Carolyn ^a,b,c,d,e   Brohi, Karim ^a,b,c,d,e   Hyde, Chris ^a,b,c,d,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UK COCHRANE CENTRE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL PRACTICE; COCHRANE LIBRARY; COLLOID; CRYSTALLOID; DIAGNOSTIC PROCEDURE; EMBASE; HEMORRHAGIC SHOCK; HUMAN; HYPOVOLEMIC SHOCK; MEDICAL LITERATURE; MEDLINE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL; SYSTEMATIC REVIEW; THROMBOELASTOGRAPHY; TRAUMA INDUCED COAGULOPATHY;

EID: 79958837159     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.01.001     Document Type: Article

References (74)

1. World Health Organisation Cause-specific mortality and morbidity http://www.who.int/whosis/whostat.
2. Cothren C.C., Moore E.E., Hedegaard H.B., et al. Epidemiology of urban trauma deaths: A comprehensive reassessment 10 years later. World J Surg 2007, 31:1507-1511.
3. Stansbury L.G., Dutton R.P., Stein D.M., et al. Controversy in trauma resuscitiation: Do ratios of plasma to red blood cells matter?. Transfus Med Rev 2009, 23:255-265.
4. Brohi K., Singh J., Heron M., et al. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
5. Maegele M., Lefering R., Yucel N., et al. Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304.
6. Spahn D.R., Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 2005, 95:130-139.
7. Kashuk J.L., Moore E.E., Sawyer M., et al. Postinjury coagulopathy management. Goal directed resuscitation via POC thromboelastography. Ann Surg 2010, 251:604-614.
8. Niles S.E., McLaughlin D.F., Perkins J.G., et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1465.
9. Hess J.R., Allison L., Stansbury L.G., et al. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma centre. Transfusion 2009, 49:34-39.
10. Macleod J.B., Lynn M., McKenny M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44.
11. Malone D.L., Dunne J., Tracy K., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54:898-907.
12. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
13. Duschesne J.C., Hunt J.P., Wahl G., et al. Review of current blood transfusion strategies in a mature level I trauma center: Were we wrong for the last 60 years?. J Trauma 2008, 65:272-278.
14. Gunter O.L., Au B.K., Isbell J.M., et al. Optimizing outcomes in damage control resuscitation: Identifying blood product ratios associated with improved survival. J Trauma 2008, 65:527-534.
15. Holcomb J.B., Wade C.E., Michalek J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
16. Kashuk J.L., Moore E.E., Johnson J.L., et al. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma: Packed red blood cells the answer?. J Trauma 2008, 65:261-270.
17. Maegele M., Lefering R., Paffrath T., et al. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: A retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang 2008, 95:122-129.
18. Scalea T.M., Bochicchio K.M., Lumpkins K., et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008, 248:578-584.
19. Sperry J.L., Ochoa J.B., Gunn S.R., et al. An FFP:PRBC transfusion ratio ≥1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008, 65:986-993.
20. Johansson P.I., Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: A before and after study. Vox Sang 2009, 96:111-118.
21. Snyder C.W., Weinberg J.A., McGwin G., et al. The relationship of blood product ratio to mortality: Survival benefit or survival bias?. J Trauma 2009, 66:358-362.
22. Teixeira P.G., Inaba K., Schulman I., et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009, 66:693-697.
23. Zink K.A., Sambasivan C.N., Holcomb J.B., et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009, 197:565-570.
24. Shaz B.H., Dente C.J., Nicholas J., et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010, 50:493-500.
25. Spinella P.C., Holcomb J.B. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:231-240.
26. Sihler K.C., Napolitano L.M. Complications of massive transfusion. Chest 2010, 137:209-220.
27. Callum J.L., Nascimento B., Tien H., et al. Editorial: "Formula-Driven" versus "Lab-Driven" massive transfusion protocols: At a state of clinical equipoise. Transfus Med Rev 2009, 23:247-254.
28. Becker L.A., Oxman A.D. Chapter 22: Overviews of reviews. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration 2008, Available from. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
29. Birchall J., Stanworth S.J., Duffy M.R., et al. Evidence for the use of Factor VIIa in the prevention and treatment of bleeding in patients without hemophilia. Transfus Med Rev 2008, 22:177-187.
30. Boldt J. Fluid choice for resuscitation of the trauma patient: A review of the physiological, pharmacological, and clinical evidence. Can J Anesth 2004, 51:500-513.
31. Bunn F., Trivedi D., Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2008, (1):CD001319. CD001319.pub2. 10.1002/14651858.
32. Carson J.L., Hill S., Carless P., et al. Transfusion triggers: A systematic review of the literature. Transfus Med Rev 2002, 16:187-199.
33. Coats T., Roberts I.G., Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2004, (4):CD004896. CD004896.pub2. 10.1002/14651858.
34. Hardy J.F., Bélisle S., Van der Linden P. Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: A review of 17 randomized controlled trials. Ann Thorac Surg 2008, 86:1038-1048.
35. Hill S.R., Carless P.A., Henry D.A., et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2000, (1):CD002042. CD002042. 10.1002/14651858.
36. Hsia C.C., Chin-Yee I.H., McAlister V.C. Use of recombinant activated factor VII in patients without hemophilia. A meta-analysis of randomised controlled trials. Ann Surg 2008, 248:61-68.
37. Kwan I., Bunn F., Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 2003, (3):CD002245. CD002245. 10.1002/14651858.
38. Lin Y., Stanworth S., Birchall J., et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Syst Rev 2007, (2):CD005011. CD005011.pub2.21. 10.1002/14651858.
39. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. A meta-analysis. JAMA 2008, 299:2304-2312.
40. Nishijima D.K., Zehtabchi S. The efficacy of recombinant activated factor VII in severe trauma. Ann Emerg Med 2009, 54:737-744.
41. Perel P., Roberts I.G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007, (4):CD000567. CD000567.pub3. 10.1002/14651858.
42. Squizzato A., Ageno W. Recombinant activated factor VII as a general haemostatic agent: Evidence-based efficacy and safety. Curr Drug Saf 2007, 2:155-161.
43. Chen J.Y., Scerbo M., Kramer G. A review of blood substitutes: Examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics 2009, 64:803-813.
44. Heier H.E., Bugge W., Hjelmeland K., et al. Transfusion vs. alternative treatment modalities in acute bleeding: A systematic review. Acta Anaesthesiol Scand 2006, 50:920-931.
45. Hill G.E., Frawley W.H., Griffith K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma 2003, 54:908-914.
46. Jansen J.O., Thomas R., Loudon M.A., et al. Damage control resuscitation for patients with major trauma. BMJ 2009, 338:1436-1440.
47. Lam M.S.H., Sims-McCallum R.P. Recombinant Factor VIIa in the treatment of non-hemophiliac bleeding. Ann Pharmacother 2005, 39:885-891.
48. Lelubre C., Piagnerelli M., Vincent J.L. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: Myth or reality?. Transfusion 2009, 49:1384-1394.
49. Levi M., Peters M., Büller H.R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit Care Med 2005, 33:883-890.
50. Mallarkey G., Brighton T., Thomson A., et al. An evaluation of Eptacog Alfa in nonhaemophiliac conditions. Drugs 2008, 68:1665-1689.
51. Murad M.H., Stubbs J.R., Gandhi M.J., et al. The effect of plasma transfusion on morbidity and mortality: A systematic review and meta-analysis. Transfusion 2010, 50:1370-1383.
52. Patanwala A.E. Factor VIIa (recombinant) for acute traumatic hemorrhage. Am J Health Syst Pharm 2008, 65:1616-1623.
53. Rose L. Recombinant factor VIIa. AACN Adv Crit Care 2007, 18:141-148.
54. Vincent J.L., Rossaint R., Riou B., et al. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-A European perspective. Crit Care 2006, 10:R120.
55. Barletta J.F., Ahrens C.L., Tyburski J.G., et al. A review of recombinant factor VII for refractory bleeding in nonhemophiliac trauma patients. J Trauma 2005, 58:646-651.
56. Cassetti M., Cassetti F.R., Rinaldi L., et al. Coagulopathy and massive blood transfusion in the trauma patients: Issues from the literature. Acta Anaesthesiol Ital 2008, 59:18-43.
57. Eastridge B.J., Malone D., Holcomb J.B. Early predictors of transfusion and mortality after injury: A review of the data-based literature. J Trauma 2006, 60:S20-S25.
58. Franchini M., Zaffanello M., Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005, 93:1027-1035.
59. Franchini M., Manzato F., Salvagno G.L., et al. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: A systematic review. Blood Coagul Fibrinolysis 2007, 18:589-593.
60. Hess J.R., Brohi K., Dutton R., et al. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008, 65:748-754.
61. Johansson P.I., Stensballe J. Hemostatic resuscitation for massive bleeding: The paradigm of plasma and platelets-A review of the current literature. Transfusion 2010, 50:701-710.
62. Mathew P. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review. Thromb Haemost 2004, 92:738-746.
63. Phan H.H., Wisner D.H. Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: What is the evidence?. Vox Sang 2010, 98:395-402.
64. Seyednejad H., Imani M., Jamieson T., et al. Topical haemostatic agents. Br J Surg 2008, 95:1197-1225.
65. Zehtabchi S., Nishijima D.K. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009, 16:371-378.
66. Boffard K.D., Riou B., Warren B., et al. Recombinant Factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two Parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-18.
67. Dutton R.P., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2003, 57:709-719.
68. Skolnick B.E., Mathews D.R., Khutoryansky N.M., et al. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood 2010, 116:693-701.
69. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 Trial Collaborators.
70. Hauser C.J., Boffard K., Dutton R., et al. CONTROL Study Group. Results of the CONTROL trial: Efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69:489-500.
71. Geeradts L.M., Kaasjager H.A., van Vugt A.B., et al. Exsanguination in trauma: A review of diagnostics and treatment options. Injury 2009, 40:11-20.
72. Brohi K., Cohen M.J., Ganter M.T., et al. Acute traumatic coagulopathy: Initiated by hypoperfusion. Modulated through the protein C pathway?. Ann Surg 2007, 245:812-818.
73. Gonzalez E.A., Moore F.A., Holcomb J.B., et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007, 62:112-119.
74. von Elm E., Altman D.G., Egger M., STROBE Initiative, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008, 61:344-349.